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We present a new method for fabricating three-dimensional 
paper-based fluidic devices that uses toner as a thermal adhesive 
to bond multiple layers of patterned paper together. The 
fabrication process is rapid, involves minimal equipment (a laser 
printer and a laminator) and produces complex channel networks 
with dimensions down to 1 mm. The devices can run multiple 
diagnostic assays on one or more samples simultaneously, can 
incorporate positive and negative controls and can be pro-
grammed to display the results of the assays in a variety of 
patterns. The patterns of the results can encode information, 
which could be used to identify counterfeit devices, identify 
samples, encrypt the results for patient privacy or monitor patient 
compliance. 
Microfluidic paper-based analytical devices (microPADs) have 
attracted much attention recently for their potential applications 
in the area of inexpensive point-of-care diagnostics.1,2 MicroPADs 
are made by patterning paper into hydrophilic channels bounded 
by hydrophobic barriers.3,4 Three-dimensional (3D) microPADs are 
made by stacking layers of patterned paper in such a way that 
channels in adjacent layers of paper connect with each other.5 
This technique expanded the capabilities of microPADs signifi-
cantly by allowing higher channel density, and therefore function, 
to be incorporated into a paper-based device without significantly 
changing the size of the device. For example, a 3D device smaller 
than a credit card can distribute samples from a single sample 
inlet into an array of over one thousand test zones where 
independent assays can be performed.5 The main drawback of 3D 
microPADs was that their fabrication was relatively complicated 
and time consuming. The original fabrication method involved 
stacking layers of patterned paper and double-sided tape.5 Other 
examples of 3D devices used an external casing to hold layers of 
paper together or relied on manual pressure to generate contact 
between different layers of paper.6,7 The Phillips group recently 
published the first simplified method for assembling 3D 
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microPADs using spray adhesive to permanently bond layers of 
paper together.8 
We present a new method for fabricating 3D microPADs using 
toner as both a thermal adhesive to bond layers of paper together 
and as an impermeable barrier to separate channels in adjacent 
layers of paper (Fig. 1). This process minimizes the number of 
layers of material that need to be aligned and assembled. We 
demonstrate that this method is rapid, technically simple to 
adopt, can produce features down to 1 mm in diameter (the 
practical size-limit of fabrication for paper-based devices) and 
involves only the use of a laser printer and a thermal laminator in 
addition to the equipment for patterning paper. The fabrication 
method provides several ways of programming fluid flow within 
the 3D devices so that the results of diagnostic tests can be 
displayed in patterns. The patterns of the results can encode 
information, much like a matrix barcode, and could have 
numerous applications in the context of point-of-care diagnostics 
and home health care. 
The fabrication of 3D microPADs using toner involves four 
steps: (i) patterning a sheet of paper, (ii) printing four layers of 
toner on the top face of the patterned paper waiting five minutes 
between each print cycle as described previously,9 (iii) folding the 
paper to generate the layered 3D device, and (iv) passing the folded 
paper through a thermal laminator to bond the layers of paper 
together (Fig. 1A). We have bonded up to eight layers of paper 
using this procedure. The entire process can be completed in 
approximately 30 min, and when multiple devices were fabricated 
in parallel, a single researcher was able to make 160 devices (each 
containing four layers of paper) in 50 min (Fig. S1). 
In this work, we used wax printing to pattern Whatman 1CHR 
paper,10 though other papers and methods of patterning should 
also be compatible with the process. Toner is a convenient 
material for fabricating 3D microPADs because it can be printed 
directly on sheets of patterned paper in well-defined patterns with 
ports to allow fluids to wick between adjacent layers of paper. We 
showed previously that toner can be used to generate imperme-
able barriers on microPADs in order to enclose and protect the 
channels in the devices.9 Toner has also been used as a thermal 
adhesive to fabricate conventional plastic-based microfluidic 
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Fig. 1 Fabrication of 3D microPADs using toner. (A) Schematic of the four steps 
to fabricate a device. (B) The top of the device after adding aqueous dyes to the 
sample inlets and allowing them to wick across the channels for 2 min. (C) The 
bottom of the device after adding aqueous dyes. (D) Cross-section of the device 
showing the layers of paper and toner. The toner bonds the layers of paper 
together and prevents fluids in adjacent channels from mixing. Ports in the 
toner layer allow fluids to wick between adjacent layers of paper. 
devices.11 In our 3D microPADs, toner serves as both a thermal 
adhesive and an impermeable barrier. 
We found that folding a sheet of patterned paper, rather than 
stacking pieces of patterned paper, was more convenient for 
aligning and assembling the layers of patterned paper in a 3D 
device. A strip of patterned paper can either be folded in a zig-zag 
pattern or folded around itself to generate the layered structure. 
These two folding patterns allow for multiple devices patterned on 
a sheet of paper to all be folded and then laminated 
simultaneously (Fig. S1). While the thermal laminator is a 
convenient and inexpensive (y$30) instrument for fabricating 
the devices, other heat sources could be used instead, such as an 
oven (set to 170 uC for one minute), a hotplate or an iron. One 
drawback of the thermal lamination step is that it will likely 
damage heat-sensitive reagents, which means heat-sensitive 
reagents would have to be applied after the device is fully 
assembled. 
To demonstrate some of the capabilities of these 3D devices, 
we prepared a variety of devices for distributing samples from four 
sample inlets on the top of the devices into arrays of 16, 25 or 64 
test zones located on the bottom of the devices (Fig. 2). The fluids 
can be distributed into virtually any pattern by modifying the 
network of channels in the middle layers of paper in the device 
(Fig. S2). 
One of the original motivations for developing microPADs was 
to produce low-cost point-of-care diagnostic devices that could be 
used to detect analytes in remote villages, in the field by first 
responders, and at home by untrained users.1 Potential challenges 
with widespread use of point-of-care diagnostics will be keeping 
track of the results of the assays; identifying counterfeit, expired or 
defective devices that may provide incorrect results; and protecting 
patient privacy. Three-dimensional microPADs offer a solution to 
all of these challenges by encoding information into the way that 
the results of colorimetric assays are displayed on the device and 
by incorporating positive and negative controls for each assay. 
A device that distributes one sample into an array of 16 test 
zones could  display the  results of a colorimetric  assay in any  one  
of 65 535 unique patterns (Fig. 3).12 If multiple assays are 
performed or a larger array of test zones is used, many more 
patterns can be achieved. The patterns of the results can be 
programmed in two different ways: (i) fluid flow can be controlled 
by changing the patterns of channels or the toner layers in the 
device so that the sample is only delivered to certain test zones 
and (ii) the reagents for the assays can be applied only in select 
test zones so that only those zones generate color changes. 
Patterned results could serve as a matrix barcode to encode 
information such as the type of assay being run, the identity of the 
sample, or the date when or location where the assay was 
performed. The patterns could be imaged and read with a camera 
phone, and the information could be automatically delivered to a 
centralized database where the results could be archived.13 This 
type of system could be useful in monitoring patient compliance 
with treatments.14 Patterned results also provide a simple system 
for identifying counterfeit devices. For example, each pattern of 
results could be associated with a unique code that could be 
printed on the device. After running the assay, the user would 
photograph the results using a camera phone and enter the code 
on the device. If the pattern and the code did not match, the user 
would know that the device was counterfeit, and the results would 
be discarded. 
To identify defective or expired devices, known amounts of 
analyte can be stored on the middle layers of paper in a device so 
that positive control assays can be run simultaneously with the 
sample, and no additional samples or fluid addition steps would 
be required to operate the device (Fig. 3G and H). To demonstrate, 
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Fig. 2 Devices that distribute four samples from sample inlets on the top of the 
device into an array of test zones on the bottom of the device. (A) Top of the 
device with four fluid inlets. Aqueous dyes were added to the sample inlets and 
allowed to wick through the devices. The top of all the devices shown in B–H are 
identical. (B–H) The bottom of the devices displaying various distribution 
patterns of the samples. Each zone on the bottom of the device could be used 
to run an assay. 
we added a 100 mM glucose solution to specific locations on a 
device and allowed it to dry before the device was folded and 
laminated (Fig. S3). After the device was assembled, reagents for a 
glucose assay were spotted in select test zones on the bottom of 
the device to form the desired pattern. The test zones that did not 
contain reagents served as negative controls. When the sample 
was added to the sample inlet, it wicked through the channels 
dissolving the dried glucose and carrying it into the test zones 
where a color change occurred in the positive control zones even if 
no glucose was present in the sample. If the device was defective, 
or the reagents were no longer active, the positive control test 
Fig. 3 Devices that encode information by displaying the results of assays in 
patterns. (A) Top of the device with a sample inlet. The sample is added to the 
top of the device and is distributed within 2 min to the test zones on the bottom 
of the device. (B) Bottom of the device with 16 test zones before adding the 
sample to the device. The reagents for a glucose assay were spotted in the test 
zones in patterns. (C–F) Examples of patterned results from a glucose assay after 
adding 20 mL of a 100 mM glucose solution to the sample inlet. A total of 
65 535 unique patterns can be achieved. (G and H) Devices displaying positive 
and negative controls along with experimental results. A 100 mM glucose 
solution was spotted and dried above the positive control test zones before the 
device was assembled. No reagents were added to the negative control zones. 
Twenty mL of a 10 mM glucose solution (G) and a 2 mM glucose solution (H) 
were added to the sample inlets to perform the assays. 
zones would not produce the expected color change, or a color 
change might be observed in a negative control test zone, and the 
results from the device would be discarded. If the device 
functioned properly, the controls could be useful for calibrating 
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and quantifying the results. The limitations to incorporating 
positive controls into a device are that the target analyte must 
survive the thermal lamination step, it must dissolve into the 
sample  as  the sample wicks  through the  device, and  it  must  be  
stable for at least the same amount of time as the reagents for the 
assay. 
Devices that incorporate positive and negative controls could 
also be useful for encrypting the results of a diagnostic test to 
protect patient privacy. If multiple positive control spots with 
different concentrations of analyte were incorporated into a 
device, the person running the test would not know which test 
zones corresponded to positive controls, negative controls and 
patient results. Only after analyzing the device using a camera 
phone or other instrument and, for example, entering a code 
supplied with the device, would the results of the test be 
accessible. 
In this paper, we present a new and simplified method for 
preparing 3D microPADs using toner and introduce the concept of 
patterned assay results. The method of fabrication can be readily 
adopted by researchers since virtually all research laboratories 
already have access to a laser printer and some type of heat source. 
By programming the configuration of the results of colorimetric 
assays into patterns and by incorporating positive and negative 
controls into a device, many of the challenges of point-of-care 
diagnostic testing can be overcome. 
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